ID   CLNH5.5
AC   CVCL_3665
SY   CLNH5
DR   CLO; CLO_0002498
DR   ATCC; HB-8206
DR   BioSample; SAMN03471080
DR   Wikidata; Q54813652
RX   Patent=US6090924;
RX   PubMed=6604917;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); HB-8206.
CC   Monoclonal antibody isotype: IgM, kappa.
CC   Monoclonal antibody target: Human cervical squamous cell carcinoma (Note=Also reacts with lung, prostate, vulva and skin cancer cells).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
ST   Source(s): ATCC
ST   Amelogenin: X,Y
ST   CSF1PO: 10,12
ST   D13S317: 11
ST   D16S539: 9,11,12
ST   D5S818: 10,11,13
ST   D7S820: 9,11
ST   TH01: 6,7,8,9
ST   TPOX: 8,11
ST   vWA: 14,17,19,20
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_D039 ! UC 729-6
CA   Hybridoma
DT   Created: 04-04-12; Last updated: 21-03-23; Version: 13
//
RX   Patent=US6090924;
RA   Handley H.H., Glassy M.C., Hagiwara H., Hagiwara Y.;
RT   "Human-Human CLNH5-specific antibodies.";
RL   Patent number US6090924, 18-Jul-2000.
//
RX   PubMed=6604917; DOI=10.1073/pnas.80.20.6327;
RA   Glassy M.C., Handley H.H., Hagiwara H., Royston I.;
RT   "UC 729-6, a human lymphoblastoid B-cell line useful for generating
RT   antibody-secreting human-human hybridomas.";
RL   Proc. Natl. Acad. Sci. U.S.A. 80:6327-6331(1983).
//